Imaging Features following Thermal Ablation of Lung Malignancies

Sophie Chheang; Feredoin Abtin; Antonio Guteirrez; Scott Genshaft; Robert Suh

doi:10.1055/s-0033-1342957

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2013; 30(02): 157-168
DOI: 10.1055/s-0033-1342957

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Imaging Features following Thermal Ablation of Lung Malignancies

Sophie Chheang

¹Division of Interventional Radiology, Department of Radiology, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, New York

,

Feredoin Abtin

²Thoracic Imaging Section, Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California

,

Antonio Guteirrez

²Thoracic Imaging Section, Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California

,

Scott Genshaft

²Thoracic Imaging Section, Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California

,

Robert Suh

²Thoracic Imaging Section, Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California

› Author Affiliations

Abstract

Percutaneous image-guided thermal ablation is gaining attraction as an effective alternative to surgical resection for patients with primary and secondary malignancies of the lung. Currently, no standard follow-up imaging protocol has been established or uniformly accepted. The early identification of residual or recurrent tumor would in theory enable the practitioner to offer expeditious retreatment or alternative treatment. This review elaborates on the imaging findings following thermal ablation, both heat- and cold-based, of nonresectable pulmonary malignancies.

Keywords

lung cancer - thermal ablation - imaging findings - positron emission tomography - computed tomography - radiofrequency - microwave - cryotherapy

Full Text

References

References
1 Surveillance Epidemiology and End Results (SEER). Available at : http://seer.cancer.gov/csr/1975_2009_pops09/
2 Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174 (1) 57-59
3 Giraud P, Antoine M, Larrouy A , et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000; 48 (4) 1015-1024
4 Abtin FG, Eradat J, Gutierrez AJ, Lee C, Fishbein MC, Suh RD. Radiofrequency ablation of lung tumors: imaging features of the postablation zone. Radiographics 2012; 32 (4) 947-969
5 Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology 2010; 254 (1) 301-307
6 Hiraki T, Tajiri N, Mimura H , et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 2006; 241 (1) 275-283
7 Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000; 217 (3) 633-646
8 Anderson EM, Lees WR, Gillams AR. Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 2009; 32 (3) 478-483
9 Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 2008; 247 (3) 871-879
10 Lee JM, Jin GY, Goldberg SN , et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004; 230 (1) 125-134
11 Yamamoto A, Nakamura K, Matsuoka T , et al. Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. AJR Am J Roentgenol 2005; 185 (5) 1299-1306
12 de Baère T, Palussière J, Aupérin A , et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 2006; 240 (2) 587-596
13 Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology 2011; 261 (2) 643-651
14 Ito N, Nakatsuka S, Inoue M , et al. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation. J Vasc Interv Radiol 2012; 23 (8) 1043-1052
15 Therasse P, Arbuck SG, Eisenhauer EA , et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92 (3) 205-216
16 Goldberg SN, Grassi CJ, Cardella JF , et al; Society of Interventional Radiology Technology Assessment Committee ; International Working Group on Image-Guided Tumor Ablation. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235 (3) 728-739
17 Hinshaw JL, Lee Jr FT. Cryoablation for liver cancer. Tech Vasc Interv Radiol 2007; 10 (1) 47-57
18 Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics 2005; 25 (Suppl. 01) S69-S83
19 Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee Jr FT. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 2005; 236 (1) 132-139
20 Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation—preliminary results. Radiology 2003; 229 (3) 821-829
21 Steinke K, King J, Glenn D, Morris DL. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 2003; 27 (5) 750-757
22 Sharma A, Digumarthy SR, Kalra MK, Lanuti M, Shepard JA. Reversible locoregional lymph node enlargement after radiofrequency ablation of lung tumors. AJR Am J Roentgenol 2010; 194 (5) 1250-1256
23 Okuma T, Okamura T, Matsuoka T , et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med 2006; 20 (2) 115-121
24 Yoo DC, Dupuy DE, Hillman SL , et al. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?. AJR Am J Roentgenol 2011; 197 (2) 334-340
25 Rose SC, Thistlethwaite PA, Sewell PE, Vance RB. Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 2006; 17 (6) 927-951 ; quiz 951
26 Chan VO, McDermott S, Malone DE, Dodd JD. Percutaneous radiofrequency ablation of lung tumors: evaluation of the literature using evidence-based techniques. J Thorac Imaging 2011; 26 (1) 18-26
27 Kawamura M, Izumi Y, Tsukada N , et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg 2006; 131 (5) 1007-1013
28 Gillams A. Tumour ablation: current role in the kidney, lung and bone. Cancer Imaging 2009; (9 Spec No A) S68-S70
29 Yamakado K, Hase S, Matsuoka T , et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 2007; 18 (3) 393-398
30 Cannella M, Cornelis F, Descat E , et al. Bronchopleural fistula after radiofrequency ablation of lung tumours. Cardiovasc Intervent Radiol 2011; 34 (Suppl. 02) S171-S174
31 Bui JT, Gaba RC, Knuttinen MG , et al. Microwave lung ablation complicated by bronchocutaneous fistula: case report and literature review. Semin Intervent Radiol 2011; 28 (2) 152-155
32 Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 2005; 185 (2) 466-471
33 Singnurkar A, Solomon SB, Gönen M, Larson SM, Schöder H. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions. J Nucl Med 2010; 51 (12) 1833-1840
34 Sakurai J, Hiraki T, Mukai T , et al. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol 2007; 18 (1 Pt 1) 141-145
35 Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 2005; 235 (1) 289-298
36 Saliken JC, McKinnon JG, Gray R. CT for monitoring cryotherapy. AJR Am J Roentgenol 1996; 166 (4) 853-855
37 Izumi Y, Oyama T, Ikeda E, Kawamura M, Kobayashi K. The acute effects of transthoracic cryoablation on normal lung evaluated in a porcine model. Ann Thorac Surg 2005; 79 (1) 318-322 ; discussion 322
38 Hinshaw JL, Littrup PJ, Durick N , et al. Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol. Cardiovasc Intervent Radiol 2010; 33 (6) 1180-1185
39 Permpongkosol S, Nicol TL, Link RE , et al. Differences in ablation size in porcine kidney, liver, and lung after cryoablation using the same ablation protocol. AJR Am J Roentgenol 2007; 188 (4) 1028-1032
40 Niu L, Li J, Chen J , et al. Comparison of dual- and triple-freeze protocols for pulmonary cryoablation in a Tibet pig model. Cryobiology 2012; 64 (3) 245-249